Investigating the Cases of COVID-19 Reinfection in Rivers State, Nigeria : An Epidemiological Study | Chapter 16 | Emerging Trends in Disease and Health Research Vol. 9

Because of a prior infection or vaccination, the immune system's antibodies have been trained to detect organisms with similar features. The degree of defence provided by convalescents' antibodies against reinfections during the COVID-19 pandemic is uncertain. Immunological research has shown that antibodies do, however, protect against severity. According to some, antibody levels make an adequate replacement for immunological defence. Research is currently being done to determine how long these convalescent antibodies remain in the body. This study was designed to investigate instances of COVID-19 reinfection in individuals who had already recovered from an initial COVID-19 infection.

This result could be connected to the individual's chronic illnesses like HIV and diabetes as well as the persistence of circulating antibodies. While more study is suggested, it is urged that everyone who is eligible, including COVID-19 convalescents with comorbidities, receive a complete immunisation. The chance of pandemic safety will rise if non-pharmaceutical therapies are adhered to consistently. This result could be connected to the individual's chronic illnesses like HIV and diabetes as well as the persistence of circulating antibodies. While more study is suggested, it is urged that everyone who is eligible, including COVID-19 convalescents with comorbidities, receive a complete immunisation. The chance of pandemic safety will rise if non-pharmaceutical therapies are adhered to consistently.

Author (s) Details:

Owhonda Golden,
Department of Public Health, Rivers State Ministry of Health, Port Harcourt, Nigeria.

Des-Wosu Ihuoma,
Department of Community Medicine, Rivers State University, Port Harcourt, Rivers State, Nigeria.

Onu Hastings,
Nigerian Field Epidemiology Program, AFENET Secretariat, Nigeria.

Rogers Kanee,
Clinton Health Access Initiative, Nigeria.

Eric Aigbogun Jr,
College of Medicine, Enugu State University of Science and Technology, Enugu State, Nigeria.

Nwadiuto Ifeoma,
Department of Public Health, Rivers State Ministry of Health, Port Harcourt, Nigeria.

Please see the link here: https://stm.bookpi.org/ETDHR-V9/article/view/7454

COVID-19 Reinfection and Its Diagnostic Approach | Chapter 12 | New Visions in Science and Technology Vol. 2

 COVID-19, which is caused by the Coronavirus strain "Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCOV-2)," has posed a serious threat to the world, and its pandemic has become the most pressing worry in health-care systems. Patients have been reported to have re-infected with the virus after being discharged. Various investigations have found a lack of reporting of COVID-19 virus in asymptomatic cases of reinfection. SARS-CoV-2 is genetically different, ruling out chronic viral shedding or reactivation. Because there is no technique for diagnosing reinfection based on a single specimen, it is recommended that paired specimens be tested for reinfection diagnosis. To reduce the spread of the virus in India, the Indian Council of Medical Research (ICMR) and the Ministry of Health and Family Welfare (MOHFW) have taken specific preventative measures. The increase in knowledge, as well as guidelines, has been proposed as a preventive intervention in the country to combat COVID-19. To fight the problem, a protocol for reinfection diagnosis is required. After a few cases were researched so far with an Indian scenario, this is a review article to study the diagnostic technique and diagnostic criteria for reinfection. These patients' whole genome sequencing provides important evidence for reinfection.

Author (S) Details

Dr. Ashish William
Department of Microbiology, Lady Hardinge Medical College and Associated Hospitals, India


Dr. Ravinder Kaur
Department of Microbiology, Lady Hardinge Medical College and Associated Hospitals, India.

View Book :- https://stm.bookpi.org/NVST-V2/article/view/3449